Zorubicin - Docslib

Sign Up
Log In
Upload

Sign Up
Log In
Upload

Home
» Tags
» Zorubicin

Zorubicin

WO 2018/175958 Al 27 September 2018 (27.09.2018) W !P O PCT
C19) United States 02) Patent Application Publication (10) Pub
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
(12) United States Patent (10) Patent No.: US 8,716.252 B2 Schafer Et Al
Section B Changed Classes/Guidelines Final
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
WO 2014/114801 Al 31 July 2014 (31.07.2014) P O P C T
(12) United States Patent (10) Patent No.: US 9,107,824 B2 Pilkiewicz Et Al
Stembook 2018.Pdf
( 12 ) Patent Application Publication ( 10 ) Pub . No .: US 2020/0222392 A1
Electronic Supplementary Material (ESI) for RSC Advances. This Journal Is © the Royal Society of Chemistry 2016
790 Antineoplastics
(12) United States Patent (1O) Patent No.: US 8,173,115 B2 Decuzzi Et Al
(12) Patent Application Publication (10) Pub. No.: US 2007/0135624 A1 Zalbudkin Et Al
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) Patent Application Publication (10) Pub. No.: US 2016/0220537 A1 GARNER Et Al
Pharmaceutical Compositions and Dosage Forms of Thalidomide
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

Top View

Virtual Screening of Inhibitors Against Spike Glycoprotein of SARS-Cov-2: a Drug Repurposing Approach
The Rediscovery of Bisantrene: a Review of the Literature John Rothman*
Profiling SLCO and SLC22 Genes in the NCI-60 Cancer Cell Lines to Identify Drug Uptake Transporters
Inhibitors of the Menin-Mll Interaction Inhibitoren Der Menin-Mll-Interaktion Inhibiteurs De L’Interaction Ménine-Mll
Open Full Page
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
Revisiting Intrathecal Therapy in Infants and Children Sharon Conroy, Martin Garnett, Michael Vloeberghs, Richard Grundy, Ian Craven, David Walker
Pharmaabkommen A1 E
(12) Patent Application Publication (10) Pub. No.: US 2004/0038904 A1 Ogden (43) Pub
C12) United States Patent (IO) Patent No.: US 9,777,013 B2 Nicolaou Et Al
Customs Tariff - Schedule Xxi - 1
MTORC1 MODULATORS Filed on Mar
Cytostatics in the Aquatic Environment: Analysis, Occurrence, and Possibilities for Removal
Design, Synthesis and Anticancer Activity of N3, N11-Bis (2-Hydroxyethyl)-14-Aryl-14H-Dibenzo [A, J] Xanthenes-3, 11-Dicarboxamide
Arylquinoline and Analog Compounds and Use Thereof to Treat Cancer David S
Tepzz 5 58¥Zb T
3 Health Impacts of Health-Care Waste
Compositions for Treating Breast Cancer

© 2024 Docslib.org Feedback